1Weissman IL, Baltimore D. Disappearing stem cells, disappearing science. Science, 2001; 292:601
2Vale PR, Isner JM, Rosenfield K. Therapeutic angiogenesis in critical limb and myocardia l ischemia. J Interv Cardiol, 2001; 14:511 ~ 528
3Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation,2001; 103: 2776 ~ 2779
4Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation, 2001; 103: 897 ~ 903
5Kalka C, Masuda H, Takahashi T, et al. Vascular endothelial growth factor( 165)gene transfer augments circulating endothelial progenitor cells in human subjects.Circ Res,2000; 86:1198 ~ 1202
6Mcheod BC, Sniecinski I, Ciavarella D, et al. Frequency of immediate adverse effects associated with therapeutic apheresis .Transfusion, 1999;39(3): 282
7Tateishi - Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone marrow cells: a pilot study and a randomised controlled trial.Lancet, 2002; 360: 427 ~ 435
8Hu J, Takatoku M, Sellers SE, et al. Analysis of origin and optimization ofexpansion and transduction of circulating peripheral blood endothelial progenitor cells in the rhesus macaque model. Hum Gene Ther, 2002;13: 2041 ~ 2050
9Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac funection.Nat Med,2001 ;7:430~ 436
10Iba O, Matsubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs.Circulation, 2002; 106:2019 ~ 2025